I am a
Home I AM A Search Login

Papers of the Week

2022 Sep

J Adv Res


Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.


Sukocheva OA, Maksoud R, Beeraka NM, Madhunapantula SRV, Sinelnikov M, Nikolenko VN, Neganova ME, Klochkov SG, Kamal M A, Staines DR, Marshall-Gradisnik S
J Adv Res. 2022 Sep; 40:179-196.
PMID: 36100326.


The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) disease (COVID-19) triggers the development of numerous pathologies and infection-linked complications and exacerbates existing pathologies in nearly all body systems. Aside from the primarily targeted respiratory organs, adverse SARS-CoV-2 effects were observed in nervous, cardiovascular, gastrointestinal/metabolic, immune, and other systems in COVID-19 survivors. Long-term effects of this viral infection have been recently observed and represent distressing sequelae recognised by the World Health Organisation (WHO) as a distinct clinical entity defined as post-COVID-19 condition. Considering the pandemic is still ongoing, more time is required to confirm post COVID-19 condition diagnosis in the COVID-19 infected cohorts, although many reported post COVID-19 symptoms overlap with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).